Esta web utiliza cookies para mejorar la experiencia del usuario. Puede obtener más información acerca del uso de cookies en el apartado Sobre las Cookies. Incluye instrucciones sobre cómo desconectarlas, si lo desea. Continuar navegando por el sitio web implica la aceptación del uso de cookies, como se describe en el apartado Sobre las Cookies.
American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004;114(1):297‐316.
Bauer J, Buttner P, Luther H, Wiecker TS, Mohrle M, Garbe C. Blue light phototherapy of neonatal jaundice does not increase the risk for melanocytic nevus development. Archives of Dermatology 2004;140(4):493‐4.
Home phototherapy for hyperbilirubinemia. http://www.cigna.com/customer_care/healthcare_professional/coverage_positions/medical/mm_0025_coveragepositioncriteria_phototherapy_for_hyperbilirubinemia.pdf (Accessed 26th Sept 2008).
Clyman 1978
Clyman RI, Rudolph AM. Patent ductus arteriosus: a new light on an old problem. Pediatric Research 1978;12(2):92‐4.
Csoma Z, Hencz P, Orvos H, Kemeny L, Dobozy A, Dosa‐Racz E, et al. Neonatal blue‐light phototherapy could increase the risk of dysplastic nevus development. Pediatrics 2007;119(5):1036‐7.
Eberhard BA, Drew JH. Perhaps vigintiphobia should only apply to infants with Rhesus erythroblastosis. Journal of Paediatrics and Child Health 1994;30(4):341‐4.
Horn AR, Kirsten GF, Kroon SM, Henning PA, Moller G, Pieper C, et al. Phototherapy and exchange transfusion for neonatal hyperbilirubinemia: neonatal academic hospitals' consensus guidelines for South African hospitals and primary care facilities. South African Medical Journal 2006;96(9):819‐24.
Keren R, Luan X, Friedman S, Saddlemire S, Cnaan A, Bhutani VK. A comparison of alternative risk‐assessment strategies for predicting significant neonatal hyperbilirubinemia in term and near‐term infants. Pediatrics 2008;121(1):e170‐9.
Maisel MJ. Jaundice. In: McDonald MG, Mullet MD, Seshia MM editor(s). Avery's neonatology: pathophysiology and management of the newborn. Philadelphia: Lippincott Williams & Wilkins, 2005:768‐846.
National Institute of Child Health and Human Development randomized, controlled trials of phototherapy for neonatal hyperbilirubinemia. Pediatrics 1985;75(2 pt 2):385‐441.
Oh 1972
Oh W, Karecki H. Phototherapy and insensible water loss in the newborn infant. American Journal of Diseases of Children 1972;124(2):230‐2.
Rosenfeld W, Sadhev S, Brunot V, Jhaveri R, Zabaleta I, Evans HE. Phototherapy effect on the incidence of patent ductus arteriosus in premature infants: prevention with chest shielding. Pediatrics 1986;78(1):10‐4.
Rudenko EB, Kalinicheva VI. Comparative evaluation of the effectiveness of various schedules of phototherapy in premature newborn infants with hyperbilirubinemia. Pediatriia 1990, (4):58‐61.
Thaithumyanon P, Visutitatmanee C. Double phototherapy in jaundiced term infants with haemolysis. Journal of the Medical Association of Thailand 2002 Nov;85(11):1176‐81.
Travadi J, Simmer K, Ramsay J, Doherty D, Hagan R. Patent ductus arteriosus in extremely preterm infants receiving phototherapy: does shielding the chest make a difference? A randimised, controlled‐trial. Acta Paediatrica 2006;95(11):1418‐23.
Vogl TP, Hegyi T, Hiatt IM, Polin RA, Indyk L. Intermediate phototherapy in the treatment of jaundice in the premature infant. Journal of Pediatrics 1978;92(4):627‐30.
Wu PY, Lim RC, Hodgman JE, Kokosky MJ, Teberg AJ. Effect of phototherapy in preterm infants on growth in the neonatal period. Journal of Pediatrics 1974;85(4):563‐6.
Todos los apartados aparecen seleccionados por defecto, por favor, seleccione los apartados que no desea imprimir o utilice el botón de seleccionar o deseleccionar todo para añadir o quitar apartados.
Seleccionar/deseleccionar todo
Los datos disponibles están protegidos por derechos de autor y sólo pueden utilizarse de acuerdo con los Términos y Condiciones.